// App-Quantinova.ai

M2072 2015 AHA : New Oral Anticoagulants: Bleeding Rates Among Medicare Beneficiaries with Atrial Fibrillation

Researchers

Presenter

  • Jeremy Smith

Principal Investigators

  • Kimon Bekelis

  • Nancy E Morden

Medical Centers

  • University of Washington, Seattle, WA

  • Geisel School of Medcn At Dartmouth, Lebanon, NH

  • Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Non-valvular atrial fibrillation

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Clopidogrel bisulfate

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved